Upgrade to SI Premium - Free Trial

Tonix Pharma (TNXP) Tops Q4 EPS by 46c

March 13, 2023 7:13 AM

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($0.56), $0.46 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

Categories

Earnings